Additional Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Beaumont Hospital, Royal Oak
    Royal Oak MI. 48073
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Indiana University Health
    Indianapolis IN. 46202
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Icahn School of Medicine at Mount Sinai
    New York NY. 10029
    View Details

  • Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

    UCLA
    Los Angeles CA. 90024
    View Details

  • MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    Centre de Recherche Clinique - CHUS
    Sherbrooke QC. J1H 5N4
    View Details

  • 129Xe MRI Cardiopulmonary

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Medical College of Wisconsin
    Milwaukee WI. 53226-1222
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Temple University Hospital
    Philadelphia PA. 19140
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    The Vanderbilt Lung Institute
    Nashville TN. 37204
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Johns Hopkins Asthma and Allergy Center
    Baltimore MD. 21224
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University of Virginia Health System
    Charlottesville VA. 22903
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Washington University School of Medicine
    Saint Louis MO. 63110
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Pennsylvania State Hershey Medical Center and College of Medicine
    Hershey PA. 17033
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    St.Paul's Hospital
    Vancouver BC. V6Z 176
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Northwestern Memorial Hospital, Clinical Research Unit
    Chicago IL. 60611
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Weill Cornell Medicine, New York-Presbyterian Hospital
    New York NY. 10065
    View Details